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Constipation and Encopresis in Children 
by Samuel Aquilina & Thomas Attard r--
Ctronlc oonst~on Is deIIned as a decraII!la In fnlq.Jency 
or IhiI painftJI P "11" of bow&! 
rncMlffiEInta prosenllor 8ElYEf'BI 
_kII. Aet!lrrII'Ia encopresis Is 1ha 
tam I'II9IIIVIId for tha irMlIlIIIBry and 
lrIOOntroIlSJle IIOIling 1hat oooul'8ln 
cI1ldren wtth c/YI:lnlc constI~. 
Coostipation is IIlIIlatiwly ocrnmcn 
paed\atr1c oomp!elni eooounthg 
for up to 3'16 ri general paedlatrt:: 
ouIpIIIiali vi!itl!I and 25% of visits 
to II paediabic gastfOOl'\ler'olcOS.' 
Enc:opresIs Is also corrrnon, 
0CCU'11111 ., at IBut 1.5% of all 
otildren. 
DBapIIB lis pravaIaroa. most 
constipation in children tends to be 
ftJnctlonai or Idlope:thlc. lhe nnJraI 
tistory offLn:tlcnal oonstlpatlon 
is that of an «IapIive pattem of 
behaviour In a ct1ld who voIlr1t8rttt 
wltttlcjdl faecer; folOW&d I:7f 
painful defecation. Retained stool 
_ntueIy loses moIstlnl to beooI.oe 
Iwdar and thus IIXIIC8rbidss tha 
pain and cilliculty Wth stoolr(l. 
EYentudy. th8 d!1ated distal ooIon 
Is ra odeoed rnacharic:IIly I iIItIIoc1IYe 
to 1fJCPII11MII'l1tt:la of normel 
consistency. Shoe encopresis 
EMlIves ttrcugh leo..,..tIM icing stool 
.eB.w. thEI dlid&d recIaIYBlA 
beoorn!Is relallY8ly lneenslave to 
tha pr ICe of 1I0oI wIich 
II95IlIieI ~de to 
oomdOUB derecaIIon. 
Rec:tal1mpactIon with 
1I0oI will oaTIproniM 
the Ilmctloneol tJtegrlty ~ 
th8 are! sphincter. and 
the prtXlIIU ilfurthlor 
~tI1rough 
th8lntermlttent 
ettempbi at treetmant 
with IaxaIHoo leooing 
to spurious darrhoea 
Wllhtddlr(l patIaTll UIUally 
follow cI1angatI in diet, toilet 
training. ti'M. vlralilresses. 
and obstacIu 10 ttw UM 
of toiet faoilliel outside the 
home hoIudlng unsanllery 
conditions or lack of prIwocy. 
A thorough history and physlcel 
examination ano crltlcelln 
!he e,,,,slntel d ~ the ct1ld with 
constIpdon. and In most C8IIB8 
is IiUllidant to ellow the doctor to 
EilJlEilJlIeh the clagl'iOll!1 of functional 
constIpdon. An appreclllllon of the 
~rrt wriilbiily i111oo1 
frequency Is essen1IaI to dellne the 
degrea of -"y of th8 prrx lSI! 
(TebIB 1). From Ihis IBbIa, one CII1 
note thlll broo9I-1'ed boblei!l P8III 
more stools then 101TTI,J1e-fed beblei!l. 
No dIIIB is gMin for 3-6 months 
old bobiEII, however exlrapolalii'VY 
It also depeo ods on wh8lher1hey 
lin! boaut- or bottIiI- fed. Salient 
historic points irdude bookgfQJnd 
other gastrolntesthel symptoms 
.,d gcwIh pararr8Iers, 11gB at, 
md dillioulty wiIh, toilet !reining, 
ClJrrerrt diet, and pr8I/k:lUs episodes 
of coostlpatlon m parIBnaI fiIIuras. 
MlJIiple, organic md behaviourel-
Sllotlonel ~ have to be 
borne In mind and. dapaodlng on 
the i1dmo; of .uepioion, ruled out 
(T1bI8 2). WItttlolclng beIeIIours of 
ct1~drB'l ndJdelllffenlng of buttocks 
or legs, wrtI91r(l, rilir(l on 1OOS, 
md assurnng lIll.llSiJ8l postures and 
avoiln behaviour. The phyIoIcai 
1IXMli11I1ion lIhCiUd i1ckJde a rectal 
exem; mportanl components of 
thlll part of the lISIII!BInIant ndJde 
irwpeclion fa SIK:reI diTopliJ and i1 
moot C8IleS d~ elIaIllInailon ~ 
the rectum to deteomlne perianal 
aenselion, 1onII, anBi n!i1ex, amount 
md conllstency of 8I00I, v.t1le 
ct1eck1ng IIICb!rnIi!IIy fer 1Issinos. skh 
tags and perianal erytteme. 
The mmagernent of the ct11d with 
1lJ1dionBI coostipetion irdudes 
I'OO!if!Uranoo and eduoaIlon ~ 
the ~ and parents. hillel 
d!impacrtia1 of reteillllCl stool 
followed by rT1IIi1tenEI.no ther'Elpf 
with 1ong-1EIm IPIIIIvEiI and 
behllvlOl.l' modlllcldlcr1. 
Education -It IIIlmporttr1t that: th8 
pethophyalologlc pm i'TvoM'1g 
stool retention, be mo;pleined in 
und~e ftYm to th8 parents. 
Encopresis. when fi rt usually 
entails an adverIEI.riEI.I inIllracIion 
beI\'.eeo. careglllenil !rid \:he pat~ 
thelidterbelng ...,- ofwlLlltary 
so~ng which Is. rroost often not 1he 
CBIIII. Othar e9p8CII of tAill!mall 
inaude an mo;plElnation oflhe 
chronicity ofihe condition along 'NIth 
long term .~ of cara . 
Dlllmp"ct:Ion - This Is neo:eelery 
before "~Iatlon of melnten&ncII 
~ II can be oohiEMld preferably 
>Mth oral medlcetlon. In I'1f8nIs, 
rBC!aI dlrnpacllon CII1 be achie-.oBCl 
wth glyooril aJppo!itoriei!i • ., 
ct1ldren. e range of medcellons eJI(Ist 
su::h II mlnBnll 011. polyathylBne 
glycol, IIlctuble, torbitoI, ger'I1EI, 
magnesium hydiQldd9 and citrate; 
IndL.dng 11181.II1II. In nIfi'actcry a-
_'" 0lIII8S, inpatiant actnission 
v.1th a Naoogastrlc tlbe pIaoemall 
IWId polyethylene glycol drlp rr&y be 
rwoeISilry. 
MIIhWI.., ...... .....,. -the aim 
here is to pllMlnl rBClmInOII. 
Dlalary chengEl8, namely IncI'OOlB ., 
Insoluble 1tn. can be 11T'flI1II.teI oted 
but ani rarwIy sulliciBrt. ~
reoont IlieraIIJre ha9 (JJOOi1oned the 
valdlty of chronic non-stlrn.lIent 
(bJk-ftYmi1g) lilxati'oW Ui!II,' ct1roric 
actn"lI!rbatloi. of a rooro-dmulElnl 
IalfatIIIe appears to be 1he stanr::i:;wd 
of CIIAI. GMin thEIllaw' IIYOUtion of 
ct1ronic con~lioo ~ md the rirIk of 
dEHeloplng. reIdveIy etonlc colon, 
patients alii LllUEliIy traetacI with non-
eti'nulont 1ilxatiw8 on along-term 
beeIs. sormrirnes for years. 
B.hDioura! modification - The 
use of medcaUons n oaTIbineilon 
'NIth behllVkxnl man.gerTlllrrt CII1 
dl'iCJeiilOO the lime to rami9i!ion i1 
ct1ldrB'l. Reguler unt'IJrrIed toilet 
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Pediatrics Continues from page 13 
Referral for further Investigation Is needed when therapy 
fails and when there is evidence of organic disease. 
Abdominal imaging is indicated only when there is doubt 
about the underlying diagnosis or to reinforce the severity of 
the problem, should the parents be hesitant to embark on 
long-term therapy. 
There is insufficient data about the long term prognosis of 
childhood constipation and its persistence into adulthood. 
A study In the Netherlands found that 60% of children 
referred to a tertiary centre for chronic constipation where 
treeled successfully at 1 year of follow up. But it also 
noted that 30% of children followed up after puberty had 
persistent distressing symptoms.8 Another study showed 
significantly better results in children referred to a tertiary 
centre, with the duration of symptoms less than 3 months 
before referral.4 
Constipation and encopresis are potentially curable. 
Children who foIlO\I\I the appropriate, usually long-term 
treatment including behaviour modification will evantually 
regain control of their bowel habits. Long term sequelae 
include relapse but this can be addressed with repeat 
therapy, although raessessment for possible underlying 
organic disease then becomes more pertinent. 
'." 
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'1lIIble 1: 
Normal frequency of bowel movements. Adapted 
from the North Amefic8n Society for PediatJic Gastroen_ Hepatology and Nutrition 
constipation guidelines, 2006 . 
Anatomic .... 1f_1ons Intesllnal ....... Of mu_ 
disorde<. 
I. NllfIriOr o2!pIilCICI iiI'UI 
, PeMc rTeS!I (saatII i1O'3I<>om6 .~~ 
• -.~ • InfflSlolel __ ayspIosoa , _ ...... 
• IIi5<wII rf¥>IlEII"Y 
. -.< ........ 
M_11e _ gastrolnlest ..... Ab.....,.."I_~ 




N.....,pathk: conditions -, 
, T.otoeted <:Of(! , Cow'$ .... ptOf1Ion nloMrllnQll 
.-......-... • .....,. o'I'l8Iai i>ga$bOn i1eedl 
• SpiW QarCI .000" ..... • VoII!fflr1 0 no..JcaIiOr1 
• SI*a' <XIf(I ,rlU'fll . ...., 
• "",-"Q6boo ,1DICllIis 
'DIble 2: 
Organic Aetiologies of Constipation In Infancy and 
Childhood . 
1.OcI1lllPliICl1 aojjelill ClormiItM, EVakJdcr1 sm 1Iw:tmenl afOcnltlpmlon n I1fInIs arI:I 
CHId""" Raccrma-.dBtJar. oflhll North ............... SocIatylcr Ped!1IIrlc calroarlta ........ ~ 
Hepatoio0' sm Nutr1IIcr1. J Pedlllr Giir.roInIW Null' 2006; 43(3);81·13. 
2.~ MM1, Tabbeni 1.1, Barri1goo. w.. at aI. OJtIert!y mcommandad __ of 
cl*llood OOilII!Plilon are nat M:tan0l bued. A~c IIeraIo.n itNIaw on the eII8ct 
of 1oilCIrtIw_ sm o:Iatary ~ Aodi OIl 0I1id 200II; 114:117...:l1. a_ GnIGI R, 
RlitsTBJB, BUIer HA. 1111. Ohljjhood COi~I.lorVIJdlnall'olow-~ bI>,'ond pltlerty. 
cab .. _ ........ 2003:125(2):357-118. 4.\lin dan EIeoiJ 101M, Von ra..m 0-1, de I.crt1 F, 
RlitsTBJB, DlloNnm C. FLIIc:act111 COI'II!jJllljon In 1tIIrrt!i; alollo:NM.ip.~ J f'8(IsIr 2006; 
~~, ___ ~_~ __ . ________________________________________ ; ___ ,._,~ __ no_._. ______________________________________ • 
CryoPen, 
Removing skin lesions in a few seconds, 
Impressive results in the removal of 
warts and skin lesions. Safe. 
effective and easy to work with and 
comlortable lor the patient. 
CryoPenlc 
• very economical8g gas cartridges 
• dosage with pinpoint precision 
• standard set with 1 micro-applicator 
• reassuring design for young patients 
The CryoPenlc is accurate to the millimeter 
so that the disavantage of collateral tissue 
damage resulting in blisters and pain is 
minimized. CryoPenlc allows beHer 
penetration to avoid repeated treatments for 
the patient. It is very suitable for the use on 
children. CryoPenlc was designed to 
optimize treatment of warts, keratosis, 
fibroma, condyloma, lentigo, .... 
CryoPenlx 
• comes with 3 micro-applicators 
• sleek and refined design 
• operates with 8g and/or 16g cartridges 
• intuitive comfort at a fingertouch 
The innovative concept of CryoPenlx allows 
you to work with pinpoint precision and with 
minimal discomfort for the patient. No 
folklw-up care and short recovery period. 
So easy to work with, you activate your 





NEW CryoPen l x 
Applications 
1-3mm 
Appl ications 
2-Smm 
o 
Applications 
4-Bmm 
